Karl Kochert
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Turning precision medicine into reality with statistics and data-driven decision making across pharmaceutical development.
Journal: Communications medicine
Published: July 31, 2025
On the Application of Artificial Intelligence/Machine Learning (AI/ML) in Late-Stage Clinical Development.
Journal: Therapeutic innovation & regulatory science
Published: January 03, 2024
Safety and activity of anti-mesothelin antibody-drug conjugate anetumab ravtansine in combination with pegylated-liposomal doxorubicin in platinum-resistant ovarian cancer: multicenter, phase Ib dose escalation and expansion study.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: December 23, 2022
Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial.
Journal: The Lancet. Oncology
Published: October 13, 2021
Aberrant Expression of and Cell Death Induction by Engagement of the MHC-II Chaperone CD74 in Anaplastic Large Cell Lymphoma (ALCL).
Journal: Cancers
Published: September 14, 2021
On-Target Pharmacodynamic Activity of the PI3K Inhibitor Copanlisib in Paired Biopsies from Patients with Malignant Lymphoma and Advanced Solid Tumors.
Journal: Molecular cancer therapeutics
Published: May 02, 2019
Biomarkers Associated With Response to Regorafenib in Patients With Hepatocellular Carcinoma.
Journal: Gastroenterology
Published: August 07, 2018
Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: March 10, 2018
Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 05, 2017
Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphoma.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 22, 2017
In situ analysis of FGFR2 mRNA and comparison with FGFR2 gene copy number by dual-color in situ hybridization in a large cohort of gastric cancer patients.
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: April 10, 2017
Canonical NF-κB signaling is uniquely required for the long-term persistence of functional mature B cells.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 22, 2016
Last Updated: 09/26/2026